Researchers can forecast risk of deadly vascular condition from genome sequence

September 6, 2018, Stanford University Medical Center
This graphical abstract illustrates how a machine-learning approach integrating personal genomes and electronic health records can predict clinical outcomes associated with abdominal aortic aneurysm and can model the effectiveness of adjusting personal lifestyles based on a given individual's genome. Credit: Li et al./Cell

A new approach that distills deluges of genetic data and patient health records has identified a set of telltale patterns that can predict a person's risk for a common, and often fatal, cardiovascular disease, according to a new study from the Stanford University School of Medicine.

Although the method, which uses a form of artificial intelligence called machine learning, has so far only been used to predict the likelihood of this particular condition—called , or AAA—it's proof that such an approach could decipher the molecular nuances that put people at risk for just about any complex genetic disease.

"Right now, genome sequencing is starting to make its mark," said Michael Snyder, Ph.D., professor and chair of genetics at Stanford. "It's being used a lot in cancer, or to solve mystery diseases. But there's still a big open question: How much can we use it for predicting ?"

It turns out, quite a bit.

Typically, researchers and use genetic testing to look for DNA sequences that may correspond to an increased risk for a particular illness. Mutations in the BRCA1 and BRCA2 genes, for instance, may signal an increased risk of breast cancer. But the method that Snyder and his colleagues developed doesn't work like that. It's not looking for one standout gene or mutation; it's looking for a slew of complex mutational patterns, and how those genetic errors play into a person's health and risk for disease.

The method seeks to identify any likely disease-causing culprits in an "agnostic" manner, meaning that it combs through an onslaught of genetic information from patients with AAA, looking for commonalities. This, Snyder said, is the key to unraveling any number of genetic diseases. It's not often the case that one, two or even a handful of genes take sole responsibility for a condition. Far more likely is that it's a whole bunch of them. The idea is that it takes a village to cause a disease, and by using this new method, those villagers can be identified.

The study will be published Sept. 6 in Cell. Snyder and Philip Tsao, Ph.D., professor of medicine, share senior authorship. Instructor Jingjing Li, Ph.D.; research manager Cuiping Pan, Ph.D.; and postdoctoral scholar Sai Zhang, Ph.D., are the lead authors.

Often diagnosed at death

AAA afflicts upward of 3 million people every year and is the 10th-leading killer in the United States. Patients with AAA have an enlarged aorta, the main artery of the body, which slowly balloons over time until, in the worst of cases, it ruptures. To make matters worse, these types of aneurysms rarely show symptoms. So in many cases, the condition silently escalates, which is in part what makes it so dangerous.

Yet AAA is pretty amenable to behavioral change. Things like smoking and high blood pressure intensify the condition, while higher levels of HDL, or "good" cholesterol, help decrease the risk. So, if people know they are at risk early on, they can ideally adjust their lifestyle to avoid exacerbation or onset altogether.

"What's important to note about AAA is that it's irreversible, so once your aorta starts enlarging, it's not like you can un-enlarge it. And typically, the disease is discovered when the aorta bursts, and by that time it's 90 percent lethal," said Snyder, the Stanford W. Ascherman, MD, FACS, Professor in Genetics. "So here's this irreversible disease, no way to predict it. No one has ever set up a predictive test for it and, just from a genome sequence, we found that we could actually predict with about 70 percent accuracy who is at high risk for AAA." When other details from electronic patient records were added, like whether a patient smoked and his or her cholesterol levels, accuracy increased to 80 percent, Snyder said.

The method Snyder and his team devised relies on an algorithm they call the Hierarchical Estimate From Agnostic Learning, or HEAL, which analyzed genomic data from 268 patients with AAA and scanned the mass of information for any genes that were found to be mutated across the population. The algorithm identified 60 genes that were hypermutated in the AAA patients. Some genes played roles in blood-vessel function and aneurysm development—a nod to HEAL's accuracy—but others, more surprisingly, were associated with regulation of immune function, revealing that the mutational landscape of this disease is complex, involving niches of physiology that weren't necessarily expected.

The team further confirmed their findings using HEAL in a control group, double-checking that the AAA-related mutational patterns were not seen among 133 healthy individuals. And indeed, there was no significant overlap.

"HEAL could, therefore, uncover new research directions and potential therapeutic targets for devastating diseases such as AAA" said Tsao, who is also the director of the Veterans Affairs Palo Alto Epidemiology Research and Information Center for Genomics.

Any disease with a genetic component

The key, Snyder said, is that the findings were entirely unbiased. The researchers didn't say, "We think gene X, Y and Z might play a role in AAA." They fed the genetic information into HEAL and asked if there were genes or sets of genes that were enriched for mutation. "We let machine learning figure it out, and that's something that, to our knowledge, has never been done before," Snyder said.

Even for diseases that have these big "red flag" genomic markers, HEAL could offer a leg up, Snyder said. "For example, in familiar cases like breast cancer, for which we know of specific 'culprit' genes, you have to remember that these genes—BRCA1, BRCA2 and a couple others—only explain about 30 percent of the genetics of the disease," Snyder said. "That means 70 percent is still unexplained. There are probably multiple and mutations involved, and that's where we think HEAL may kick in big time."

In their next phase of work, Snyder and his group are looking into using HEAL to detect the elusive genetic underpinnings of preterm birth and autism.

"I see a future in which everyone will be born with their genome sequenced, or shortly thereafter," Snyder said. "Both your single-gene and your complex disease risk will be used to predict your overall disease risk, and then you can take action based on that information."

The work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat in the ill.

Explore further: Diabetic-level glucose spikes seen in healthy people, study finds

More information: Cell, Li et al.: "Decoding the Genomics of Abdominal Aortic Aneurysm" , DOI: 10.1016/j.cell.2018.07.021

Related Stories

Diabetic-level glucose spikes seen in healthy people, study finds

July 24, 2018
A device that keeps extra-close tabs on the ups and downs of blood glucose levels reveals that most people see only a partial picture of the sugar circulating in their blood, according to a study by researchers at the Stanford ...

Paper identifies genes associated with risk for aggressive breast cancer

August 7, 2018
A new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk for triple-negative breast cancer, providing the basis for better risk management.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Mapping the genetic controllers in heart disease

July 10, 2018
Researchers have developed a 3-D map of the gene interactions that play a key role in cardiovascular disease, a study in eLife reports.

New genes associated with breast cancer risk

June 26, 2018
Only a small percentage of breast cancer cases can be linked to heredity, and many of the genes with ties to the disease are unknown.

Molecular network identified underlying autism spectrum disorders

December 30, 2014
Researchers in the United States have identified a molecular network that comprises many of the genes previously shown to contribute to autism spectrum disorders. The findings provide a map of some of the crucial protein ...

Recommended for you

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Decrease in specific gene 'silencing' molecules linked with pediatric brain tumors

November 12, 2018
Experimenting with lab-grown brain cancer cells, Johns Hopkins Medicine researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric ...

Recessive genes explain only small fraction of undiagnosed developmental disorders

November 8, 2018
The Deciphering Developmental Disorders study has discovered that only a small fraction of rare, undiagnosed developmental disorders in the British Isles are caused by recessive genes. The study by researchers from the Wellcome ...

A look at how colds and chronic disease affect DNA expression

November 8, 2018
We're all born with a DNA sequence that encodes (in the form of genes) the very traits that make us, us—eye color, height, and even personality. We think of those genes as unchanging, but in reality, the way they are expressed, ...

Mutant protein tackles DNA guardian to promote cancer development

November 7, 2018
Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Sep 07, 2018
The first paragraph was

"A new approach that distills deluges of genetic data and patient health records has identified a set of telltale patterns that can predict a person's risk for a common, and often fatal, cardiovascular disease, according to a new study from the Stanford University School of Medicine."

Note that the first paragraph mentioned the name of the university, but not the name of the actual disease.

The name of the disease was the most important information.

This is terrible journalism.

The piece was actually a propaganda piece from Stanford provided to medicalxpress.

While it was very important to the researchers' mothers that their sons be mentioned it is of almost no importance to the reader. I do though think it should be mentioned, but that this sort of thing should be only secondary to the real information.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.